BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Boston Therapeutics, Inc. 

1750 Elm Street, Suite 103

Manchester  New Hampshire  03104  U.S.A.
Phone: 603-935-9799 Fax: 603-685-4784


SEARCH JOBS




Industry
Pharmaceutical






 Company News
Boston Therapeutics, Inc. Announces FDA Acceptance Of IND To Initiate A Clinical Trial Of BTI-320 To Treat Type ll Diabetes And Weight Loss 12/11/2014 8:14:14 AM
Boston Therapeutics, Inc. and Advance Pharmaceutical Expand Agreement To Market Sugardown® In 12 Additional Countries In Asia 11/24/2014 9:48:37 AM
Boston Therapeutics, Inc. Initiates Clinical Study At Sydney University To Evaluate sSugardown® With Sugary Beverage Consumption 11/19/2014 12:57:52 PM
Boston Therapeutics, Inc. Reports Third Quarter Results And Provides Corporate Update 11/10/2014 10:50:05 AM
Boston Therapeutics, Inc. Announces The North America Branding Of Sugardown®: A New Natural Product That Helps Maintain Healthy Blood Sugar Levels 11/4/2014 1:08:22 PM
Boston Therapeutics, Inc. Reports Topline U.S.-Based Phase 2b Study Results Of BTI-320 In Patients With Type 2 Diabetes 10/9/2014 8:01:18 AM
Boston Therapeutics, Inc. Appoints David S.H. Bell, MB, FACP, FACE To Its Medical Advisory Board 10/8/2014 9:36:16 AM
Boston Therapeutics, Inc. Files Patent Application For Novel Therapeutic Uses Of BTI-320 10/7/2014 10:22:15 AM
Boston Therapeutics, Inc. Appoints Jan Brinkman, M.D., Ph.D. And Alan M. Hoberman, Ph.D. To Board Of Directors 10/2/2014 10:53:56 AM
Benchworks Collaborates With Boston Therapeutics, Inc. To Market Sugardown® 9/29/2014 12:28:26 PM
12345678